Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men
- PMID: 19775201
- PMCID: PMC3121172
- DOI: 10.1359/jbmr.090826
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men
Abstract
The association between vitamin D levels and incident fractures in older men is uncertain. To test the hypothesis that low serum 25-hydroxyvitamin D [(25(OH)D] levels are associated with an increased risk of fracture, we performed a case-cohort study of 436 men with incident nonspine fractures, including 81 hip fractures, and a random subcohort of 1608 men; average follow-up time 5.3 years. Serum vitamin D(2) and vitamin D(3) were measured on baseline sera using mass spectrometry and summed for total vitamin D. Modified Cox proportional hazards models were used to estimate the hazard ratio (HR) of fracture with 95% confidence intervals (CIs). Multivariable models included age, clinic, season, race, height, weight, and physical activity. The mean (SD) total 25(OH)D was 24.6 (7.8) ng/mL in nonspine fracture subjects, 21.5 (7.9) ng/mL in hip fracture subjects, and 25.2 (7.8) ng/mL in controls (nonspine fracture subjects versus nonpatients, p = .14; hip fracture subjects versus controls, p < .0001). 25(OH)D levels were unrelated to nonspine fractures. One SD decrease in total 25(OH)D was associated with an increased risk of hip fracture (multivariate HR = 1.60; 95% CI 1.18-2.17). Compared with men in the top quartile of total 25(OH)D (> or =28), the HR of hip fracture was 2.36 (95% CI 1.08-5.15) for men in the lowest quartile (<20) (p = .009 for trend). Adjusting for hip bone mineral density attenuated the association by more than 50% (p = .065 for trend). Low serum 25(OH)D concentrations are associated with a higher risk of hip fracture in older men. Measurement of 25(OH)D may be useful in identifying men at high risk of hip fracture.
Copyright 2010 American Society for Bone and Mineral Research.
Figures
References
-
- Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501. - PubMed
-
- Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–777. - PubMed
-
- Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–783. - PubMed
-
- LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999;281:1505–1511. - PubMed
-
- Cranney A, Horsley T, O'Donnell T, et al. Effectiveness and safety of vitamin D in relation to bone health. 2007. Evidence report/technical assessment no. 158. Prepared by the Univerisity of Ottawa Evidence-based Practice Center (UO-EPC) under contract no. 290-02-0021. AHRQ publication no. 07-E013. Rockville, MD: Agency for Healthcare Research and Quality. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- U01 AR45583/AR/NIAMS NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
